ur products and the size of our markets;
changes in business strategy or development plans; changes in, or the
failure to comply with, governmental regulations; fluctuations in interest
rates and foreign exchange rates; seasonality including government budget
cycles; general economic and business conditions where we operate; and
other factors referenced in our annual report, our Annual Information Form
(AIF) (Form 40-F in the U.S.) and other filings with Canadian and United
States securities regulatory authorities.
Given these uncertainties, assumptions and risks, readers are cautioned
not to place undue reliance on such forward-looking statements or
information. We disclaim any obligation to update, or to publicly announce
any revisions to, any such statements or information to reflect future
results, events or developments.
CONTACT: Response Biomedical Contacts: Bill Wickson, Manager, Investor
Relations, Response Biomedical Corporation, Tel (604) 456-6073, Email:
bwickson@responsebio.com; Brian Korb, Vice President, The Trout Group LLC,
Tel: (646) 378-2923, Email: bkorb@troutgroup.com
'/>"/>SOURCE Response Biomedical Corp. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Tumors use enzyme to recruit regulatory T-cells and suppress immune response2.
Study identifies key player in the bodys immune response to chronic stress3.
Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.4.
Response Biomedical appoints S. Wayne Kay Chief Executive Officer5.
Merck & Co., Inc. Response to Todays New York Medicaid Suit6.
Maternal depression and controlling behavior associated with increased stress response in infants7.
Family history of alcoholism affects response to drug used to treat heavy drinking8.
Molecular fingerprint of breast-cancer drug resistance can predict response to treatment9.
Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer10.
PET scans can accurately detect a breast tumors response to chemotherapy11.
DNA damage response confers a barrier for viral tumorigenesis